BODY IRON LEVELS ARE CONTROLLED by intestinal absorption, as no active excretory mechanism exists for this essential trace mineral. As such, intestinal iron transport is tightly regulated by local and systemic factors. Previous studies dating back many decades have implicated copper as being important for control of body iron homeostasis (11, 14) . Relevant observations include hepatic copper loading during iron deficiency (28, 29, 32) and concomitant increased production of a liverderived, circulating multi-copper ferroxidase, ceruloplasmin (Cp) (28) . It has also been noted that serum copper levels increase during iron deficiency in a number of mammalian species (5, 28) , likely reflecting higher levels of the holo-Cp (i.e., copper-containing) enzyme (21, 26, 37) . Cp is necessary for iron release from body stores (17, 19) and may influence intestinal iron absorption (7) . At the level of the intestine, another multi-copper ferroxidase, hephaestin, is important for iron efflux from enterocytes (1, 38) ; its expression, however, is not strongly regulated by iron levels (6, 8, 15) . Additional published studies described perturbations in intestinal copper metabolism during iron deprivation, as exemplified by copper accumulation in the intestinal mucosa (29) , and increased expression of a cytoplasmic copper-binding protein [metallothionein (Mt)] and a copper exporter [Menkes copper ATPase (Atp7a)] (8, 29) . Whether copper directly influences intestinal iron absorption or if the metal is simply traversing enterocytes en route to the liver, where copper increases during iron deprivation, is not known. In either case, it is logical to predict that copper positively influences intestinal iron homeostasis.
The rate-limiting step in acquisition of dietary copper is via the Menkes copper-transporting ATPase (Atp7a), which is necessary for assimilation of absorbed copper. This is reflected by the phenotype of patients with Menkes disease, in which mutated Atp7a leads to copper accumulation in enterocytes and severe systemic copper deficiency (13, 39) . Interestingly, Atp7a is strongly induced in the duodenum of iron-deficient rats (8, 29) , in the setting of perturbations in body copper levels. A recent investigation revealed that Atp7a was coordinately regulated in intestinal epithelial cells, along with genes encoding proteins involved in intestinal iron absorption [e.g., divalent metal transporter 1 (Dmt1), cytochrome b reductase 1 (Cybrd1), and ferroportin 1 (Fpn1)], by a transcriptional mechanism mediated by a hypoxia-inducible trans-acting factor, hypoxia inducible factor 2␣ (Hif2␣) (23, 27, 31, 34) . It was, however, noted that Atp7a protein levels were more strongly induced than mRNA levels (29) , suggesting that additional regulatory mechanisms exist. The current study was thus undertaken to assess this possibility in an established model of the rodent intestinal epithelium, rat intestinal epithelial (IEC-6) cells, which express proteins involved in intestinal iron and copper absorption, including Dmt1 (35, 36) and Atp7a (10, 24) . Iron deprivation and copper-loading studies in IEC-6 cells revealed that copper had a direct influence on Atp7a protein expression independent of changes in mRNA levels.
MATERIALS AND METHODS
Cell culture. Rat IEC-6 cells were obtained from the American Type Culture Collection (Manassas, VA) and cultured as previously described (40) , according to the distributor's recommendations. The half-life of Atp7a protein was determined by treatment of 7-dayspostconfluent IEC-6 cells with the protein translation inhibitor cycloheximide (CHX; 2, 5, or 10 g/ml) for 24, 48, or 60 h. For Atp7a protein stability experiments, IEC-6 cells were cultured for 7 days postconfluence and then treated with CHX, 200 M deferoxamine (DFO, an iron chelator), and/or 200 M CuCl 2 for 48 h.
Total RNA isolation and real-time quantitative RT-PCR. IEC-6 cells at ϳ85% confluence were washed three times with ice-cold PBS (pH 7.4). Total RNA was subsequently isolated from cells using TRIzol reagent (Life Technologies, Grand Island, NY) according to the manufacturer's instructions. RNA concentration was determined using a spectrophotometer, and 1 g of total RNA was reversetranscribed with the iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA) in a 20-l reaction. After reverse transcription, cDNA was diluted to 120 l with nuclease-free water, and 3 l were used for quantitative real-time PCR (qRT-PCR) with SYBR Green qRT-PCR Master Mix (Bio-Rad), as described previously (40) . Expression of experimental genes was normalized to expression of a "housekeeping" gene, 18S rRNA, which fluctuated minimally between samples. The sequences of primers used for the qRT-PCR experiments are listed in Table 1 . First, validation of each primer pair was accomplished by standard curve reactions, whereby linear amplification was observed across a range of template concentrations. Melt curves were also routinely run with each PCR reaction to ensure that single amplicons were produced.
Protein isolation and Western blotting. Total cellular protein was purified with the Nuclear Extraction Kit (Active Motif, Carlsbad, CA), as described previously with minor modifications (40) . IEC-6 cells at ϳ85% confluence were washed with ice-cold PBS (pH 7.4), harvested using a cell scraper, and then suspended in 1ϫ hypotonic buffer plus protease inhibitor cocktail [2 M leupeptin, 14 M E-64, 130 M bestatin, and 2 mM 4-(2-aminoethyl) benzene sulfonylfluoride HCl]. Cells were lysed using a tissue homogenizer, and membrane-bound proteins were solubilized with NP-40 (0.05%). A total cell lysate, minus nuclear protein, was obtained by centrifugation at 16,000 rpm in a microfuge for 15 min at 4°C. Protein concentration in the resulting supernatant was determined using a BCA Protein Assay Kit (Thermo Scientific, Rockford, IL). Protein (30 g) was resolved by 7.5% SDS-PAGE and then transferred to a polyvinylidene difluoride membrane, which was blocked in 5% nonfat milk. The membrane was then reacted with a rabbit polyclonal antibody against the rat Atp7a protein (54-10), which has been extensively validated (10, 24, 40) . Antibodies against ␤-actin (600-403-886, Rockland, Gilbertsville, PA) and tubulin (ab6160, Abcam, Cambridge, MA) were also utilized to detect constitutively expressed "housekeeping" proteins for normalization. For some experiments, Atp7a protein expression was normalized to total proteins on stained blots, as previously described (22, 28) . Immunoreactive proteins on membranes were visualized using in-house-made enhanced chemiluminescence reagent (28) and X-ray film.
Statistical analysis. ANOVA (GraphPad, La Jolla, CA) was utilized to statistically compare experimental data across groups; P Ͻ 0.05 was considered significant.
RESULTS

Atp7a expression is upregulated by iron chelation and copper loading.
To model the in vivo situation during iron deficiency and to decipher mechanistic aspects of Atp7a regulation during iron deficiency, IEC-6 cells were treated with an iron chelator (DFO) and/or extra copper was added to the culture medium. Iron chelation increased Atp7a mRNA expression (ϳ1.6-fold) but had little effect on protein levels (Fig. 1) . Iron chelation (200 M DFO) plus copper loading (200 M CuCl 2 ) had a more dramatic effect on Atp7a expression, leading to significant induction of mRNA (ϳ2.6-fold) and protein (ϳ2-fold) levels. Additionally, copper loading (200 M for 16 h) in the absence of iron chelation had no effect on Atp7a mRNA expression but led to a significant increase (ϳ1.8-fold) of protein levels (Fig. 1) . On the basis of microscopic observation of cells, none of the treatments led to significant cell death (data not shown).
Effect of copper loading on Atp7a expression. To further investigate the effect of copper loading on Atp7a protein expression, IEC-6 cells were treated with increasing concentrations of copper in the cell culture medium for 16 h, and Atp7a mRNA and protein expression levels were quantified. Increased intracellular copper was confirmed by dose-dependent increases in Mt (Mt1a/2a) mRNA expression (Fig. 2) . Mt has been shown to be a sensitive marker of intracellular copper accumulation in a number of mammalian species (3, 33) . Treatment with 100 -400 M copper did not lead to significant cell stress, as determined by microscopic observation, but higher levels (e.g., 500 and 600 M) resulted in notable cell death, as exemplified by detached, floating cells (data not shown). Atp7a mRNA expression was not affected by copper treatment at any concentration; however, Atp7a protein levels increased at all copper concentrations, with the maximal response (ϳ2-fold) observed with 200 M copper. Higher copper levels (300 and 400 M) did not lead to further increase of Atp7a protein levels. Furthermore, mRNA levels of additional copper-related genes, including copper transporter 1 (the apical copper importer), SOD1 (an intracellular copper-containing antioxidant protein), and antioxidant protein 1 (Atox1, a copper chaperone for Atp7a), were also not affected by copper loading (Fig. 3) .
Effect of copper loading on Atp7a protein stability. Since Atp7a physically interacts with copper as part of its transport function, we next considered the possibility that increased intracellular copper could increase Atp7a protein stability. A global translation inhibitor, CHX, was thus utilized in the IEC-6 cell model. As rapidly dividing IEC-6 cells are very sensitive to CHX treatment (data not shown), these experiments were done in fully confluent (7 days postconfluent) cell monolayers. First, IEC-6 cells were treated with increasing CHX concentrations to assess the effect on Atp7a protein levels (Fig. 4A) . A maximal (ϳ80%) reduction in protein levels was observed with 10 g/ml CHX for 48 h. Then, to estimate Atp7a protein half-life, cells were treated with 10 g/ml CHX for 24 -60 h (Fig. 4B) . These experiments revealed that the Atp7a protein half-life was ϳ41 h, as at this time point, protein levels had decreased ϳ50%. Next, to determine if copper loading altered Atp7a protein stability, cells were treated with CHX in the presence and absence of copper (Fig. 4C) . In this study, CHX decreased Atp7a protein levels, while CHX in the presence of copper abolished the decrease. As expected, DFO plus copper also led to an increase of Atp7a protein levels.
DISCUSSION
Consistent with alterations in body copper levels during iron deficiency, intestinal Atp7a mRNA and protein are induced in the setting of increased mucosal copper in iron-deprived rats experiments. Significance indicated as described in Fig. 1 legend. (8, 29) . To determine the molecular mechanism of this induction, we utilized an established model of the mammalian intestinal epithelium, rat IEC-6 cells. Cells were treated with CoCl 2 or cultured in 1% oxygen to simulate the hypoxic response that typifies iron deprivation (40) . These studies revealed that the Atp7a gene was a direct target of a hypoxiainducible, trans-acting factor, Hif2␣, which likely mediates increases in Atp7a mRNA expression during iron deprivation (40) . This places Atp7a among a group of iron-related genes (e.g., Cybrd1, Dmt1, and Fpn1) that are also Hif2␣ targets (27, 31, 34) . Furthermore, in iron-deficient rats, we consistently noted that Atp7a protein levels increased more dramatically than mRNA levels, perhaps hinting at an additional regulatory mechanism. This seemed even more plausible, given that Atp7a protein levels increased more dramatically in the IEC-6 cell model when cells were treated with an iron chelator in the presence of added copper. The current studies were thus undertaken to consider the possibility that copper has a direct role in stabilizing the Atp7a protein.
In the current and past studies (10), DFO treatment increased Atp7a mRNA levels in IEC-6 cells, possibly by a HIF-mediated mechanism, as iron chelation is known to stabilize the HIF proteins (similar to low oxygen or CoCl 2 exposure) (4, 20, 30) . Induction of mRNA expression was more pronounced in the presence of added copper (Fig. 1) , which presumably increased intracellular copper levels, as indicated by induction of Mt1a/ Mt2a expression. How intracellular copper accumulation could enhance the effect of DFO on Atp7a gene expression is not known. Furthermore, although iron chelation alone did not affect Atp7a protein levels, DFO plus added copper led to an increase. Contrary to our expectation, copper loading in the absence of DFO also increased Atp7a protein levels, while it did not affect mRNA expression. These observations suggested that two independent regulatory mechanisms were involved in Atp7a induction in IEC-6 cells: 1) a possible HIF-related transcriptional mechanism that increased mRNA levels and 2) a posttranscriptional mechanism acting directly on the Atp7a protein. Additional experiments were thus designed to delve into the effect of copper loading on Atp7a protein levels.
CHX is commonly used to globally inhibit protein translation, whereby one can assess the rate of protein decay in the absence of synthesis. In the IEC-6 cell model, we thus utilized CHX to determine 1) the relative stability of the Atp7a protein and 2) whether it was altered by copper loading of cells. Once a suitable concentration of CHX, i.e., a concentration that significantly attenuated Atp7a protein expression and was not toxic to the cells (10 g/ml), was identified, a time course was performed to assess Atp7a protein decay rate. Results revealed an ϳ41-h half-life for the Atp7a protein. Importantly, further experiments showed that Atp7a protein decay was significantly inhibited by loading cells with copper in the presence of CHX, most likely indicating that copper interacted with and stabilized the protein.
Copper has been shown to stabilize proteins in which it plays a catalytic role. For example, apo-Cp (which is devoid of copper) is much less stable than holo-Cp (which contains copper) (18) . Copper also stabilizes the cytosolic metal storage protein Mt (12) . In the current investigation, however, copper interaction with the protein is more transient in nature, as Atp7a is a trans-membrane copper transporter. Atp7a has six cytosolic, NH 2 -terminal copper-binding domains (25) , although all six are not required for copper transport function or trafficking from trans-Golgi to the plasma membrane in cells (16) . As such, we postulate that increased intracellular copper allows for specific binding to one or more of the intracellular copper-binding domains, leading to stabilization of the protein. How or if this might influence transport activity or protein trafficking is not known.
This investigation has thus successfully modeled in vitro what may be occurring to Atp7a gene and protein expression in vivo during iron deprivation, when enterocyte iron levels are low and hypoxia occurs and mucosal copper levels increase. Iron chelation with DFO, which presumably decreases intracellular iron and stabilizes the HIFs, increased Atp7a mRNA expression, while copper loading had an additional, synergistic effect. Use of a translation inhibitor revealed a direct influence of copper on Atp7a protein stability. A novel paradigm is thus revealed in which Atp7a protein expression increases as a result of two diverse signals: 1) HIF signaling and 2) alterations in intracellular copper content. The existence of two independent regulatory mechanisms for copper homeostasis in enterocytes specifically during perturbations in iron levels strengthens the hypothesis that copper has a positive influence on intestinal iron absorption. Whether other copper or iron homeostasis-related proteins may be similarly regulated by interaction with intracellular copper in enterocytes is unknown. Interestingly, however, the predominant intestinal iron importer, Dmt1, can bind to and transport copper (2) , but the physiological significance of such an interaction is not clear. 
